Production of specific polyclonal antibodies anti-human factor IX

In this work, polyclonal antibodies anti-human Factor IX were produced in New Zealand rabbits by immunization with commercial pure human FIX (hFIX) (Octanyne®, Octapharma, USA). The serum containing immunoglobulins anti-hFIX was useful to detect hFIX antigen in human plasma fractions submitted to an...

Full description

Bibliographic Details
Main Authors: Daniel Gonçalves Chaves, Cibele Velloso Rodrigues, Wanderley Almeida Ferreira, Pollyana Fantini Miranda Siqueira, Clara Guerra Duarte, Anna Bárbara de Freitas Carneiro-Proietti, Marcelo Matos Santoro
Format: Article
Language:English
Published: Instituto de Tecnologia do Paraná (Tecpar) 2006-07-01
Series:Brazilian Archives of Biology and Technology
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-89132006000500010
_version_ 1818561534703435776
author Daniel Gonçalves Chaves
Cibele Velloso Rodrigues
Wanderley Almeida Ferreira
Pollyana Fantini Miranda Siqueira
Clara Guerra Duarte
Anna Bárbara de Freitas Carneiro-Proietti
Marcelo Matos Santoro
author_facet Daniel Gonçalves Chaves
Cibele Velloso Rodrigues
Wanderley Almeida Ferreira
Pollyana Fantini Miranda Siqueira
Clara Guerra Duarte
Anna Bárbara de Freitas Carneiro-Proietti
Marcelo Matos Santoro
author_sort Daniel Gonçalves Chaves
collection DOAJ
description In this work, polyclonal antibodies anti-human Factor IX were produced in New Zealand rabbits by immunization with commercial pure human FIX (hFIX) (Octanyne®, Octapharma, USA). The serum containing immunoglobulins anti-hFIX was useful to detect hFIX antigen in human plasma fractions submitted to anionic exchange chromatographic process and with a large yield. Immunoassays (ELISA) using bovine serum albumin, trypsin and peptides generated by cleavage assays with trypsin as digestion enzyme was performed and revealed adequate specificity of the polyclonal antibodies produced.<br>Neste trabalho foram produzidos anticorpos policlonais anti-fator IX humano em coelhos New Zealand imunizados com FIX humano (hFIX) comercial puro (Octanyne®, Octapharma, EUA). O soro contendo as imunoglobulinas anti-hFIX foi útil para a detecção do antígeno hFIX em frações do plasma humano submetido a cromatografia de troca iônica. Imunoensaios (ELISA) usando soro-albumina bovina, tripsina e peptídeos gerados por ensaios de clivagem com tripsina com enzima de digestão foram realizados e revelaram especificidade adequada dos anticorpos policlonais produzidos.
first_indexed 2024-12-14T00:52:06Z
format Article
id doaj.art-ee04409a665c432ebf041b37ec1cc305
institution Directory Open Access Journal
issn 1516-8913
1678-4324
language English
last_indexed 2024-12-14T00:52:06Z
publishDate 2006-07-01
publisher Instituto de Tecnologia do Paraná (Tecpar)
record_format Article
series Brazilian Archives of Biology and Technology
spelling doaj.art-ee04409a665c432ebf041b37ec1cc3052022-12-21T23:23:47ZengInstituto de Tecnologia do Paraná (Tecpar)Brazilian Archives of Biology and Technology1516-89131678-43242006-07-0149460560910.1590/S1516-89132006000500010Production of specific polyclonal antibodies anti-human factor IXDaniel Gonçalves ChavesCibele Velloso RodriguesWanderley Almeida FerreiraPollyana Fantini Miranda SiqueiraClara Guerra DuarteAnna Bárbara de Freitas Carneiro-ProiettiMarcelo Matos SantoroIn this work, polyclonal antibodies anti-human Factor IX were produced in New Zealand rabbits by immunization with commercial pure human FIX (hFIX) (Octanyne®, Octapharma, USA). The serum containing immunoglobulins anti-hFIX was useful to detect hFIX antigen in human plasma fractions submitted to anionic exchange chromatographic process and with a large yield. Immunoassays (ELISA) using bovine serum albumin, trypsin and peptides generated by cleavage assays with trypsin as digestion enzyme was performed and revealed adequate specificity of the polyclonal antibodies produced.<br>Neste trabalho foram produzidos anticorpos policlonais anti-fator IX humano em coelhos New Zealand imunizados com FIX humano (hFIX) comercial puro (Octanyne®, Octapharma, EUA). O soro contendo as imunoglobulinas anti-hFIX foi útil para a detecção do antígeno hFIX em frações do plasma humano submetido a cromatografia de troca iônica. Imunoensaios (ELISA) usando soro-albumina bovina, tripsina e peptídeos gerados por ensaios de clivagem com tripsina com enzima de digestão foram realizados e revelaram especificidade adequada dos anticorpos policlonais produzidos.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-89132006000500010Factor IXhemophilia BHPLCpurificationantibodiesELISA
spellingShingle Daniel Gonçalves Chaves
Cibele Velloso Rodrigues
Wanderley Almeida Ferreira
Pollyana Fantini Miranda Siqueira
Clara Guerra Duarte
Anna Bárbara de Freitas Carneiro-Proietti
Marcelo Matos Santoro
Production of specific polyclonal antibodies anti-human factor IX
Brazilian Archives of Biology and Technology
Factor IX
hemophilia B
HPLC
purification
antibodies
ELISA
title Production of specific polyclonal antibodies anti-human factor IX
title_full Production of specific polyclonal antibodies anti-human factor IX
title_fullStr Production of specific polyclonal antibodies anti-human factor IX
title_full_unstemmed Production of specific polyclonal antibodies anti-human factor IX
title_short Production of specific polyclonal antibodies anti-human factor IX
title_sort production of specific polyclonal antibodies anti human factor ix
topic Factor IX
hemophilia B
HPLC
purification
antibodies
ELISA
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-89132006000500010
work_keys_str_mv AT danielgoncalveschaves productionofspecificpolyclonalantibodiesantihumanfactorix
AT cibelevellosorodrigues productionofspecificpolyclonalantibodiesantihumanfactorix
AT wanderleyalmeidaferreira productionofspecificpolyclonalantibodiesantihumanfactorix
AT pollyanafantinimirandasiqueira productionofspecificpolyclonalantibodiesantihumanfactorix
AT claraguerraduarte productionofspecificpolyclonalantibodiesantihumanfactorix
AT annabarbaradefreitascarneiroproietti productionofspecificpolyclonalantibodiesantihumanfactorix
AT marcelomatossantoro productionofspecificpolyclonalantibodiesantihumanfactorix